---
title: "HSN Code for Other | Anticancer Drugs | HSN 30049049 GST Rate"
description: "Find HSN and GST Rates for 30049049 related to Other | Anticancer Drugs with BUSY Accounting - The reliable source for HSN and GST details in India."
canonical: "https://busy.in/hsn/hsn-30049049/"
---

# HSN Code 30049049: Other | Anticancer Drugs

- [Section 06: Guide to HSN Section 06](https://busy.in/hsn/section-06/)
- [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/)
- [Sub-chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/)

## GST rates

| Description | CGST | SGST | IGST | CESS |
| --- | --- | --- | --- | --- |
| Other : Anticancer drugs : Other | 6% | 6% | 12% | 0% |

## Frequently asked questions

### What products are classified under HSN 30049049 ?

It includes Other | Anticancer Drugs

### Any common misclassification issue with Other / Anticancer Drugs?

Use the exact HSN and describe the form/grade. For multi‑line invoices, apply the rate per line to avoid wrong tax collection.

### Does packaging or labelling change the GST for Other / Anticancer Drugs?

For food/agri items, GST can be 5% when not fresh/chilled and sold as pre‑packaged & labelled; otherwise often Nil. For non‑food items, rates depend on the specific sub‑heading.

### Do e‑way bill and e‑invoice apply for Other / Anticancer Drugs?

e‑Way bill is needed above ₹50,000 consignment value (subject to exemptions). e‑Invoicing is turnover‑based (presently AATO > ₹5 crore) for B2B supplies.

### How should mixed supplies be billed when Other / Anticancer Drugs is sold with other items?

Use separate invoice lines per HSN and apply the correct rate per line (e.g., Varies for Other / Anticancer Drugs; Nil for exempt items if applicable).

### Can we claim ITC on inputs used to trade Other / Anticancer Drugs?

If your outward supply is taxable, eligible ITC is available subject to general restrictions. For exempt/Nil supplies, reverse credit per Rule 42.

## India's trade performance: HSN Code 30049049 (FY 2024-25)

Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25).

- Exports: ₹19,872 Cr (+55.35% YoY) — 0.5399% of India's total exports
- Imports: ₹384 Cr (+47.95% YoY) — 0.0063% of India's total imports
- Trade balance: ₹19,488 Cr (Surplus); surplus rank #18 of 12657 HSN codes
- Share of Sub-Chapter 3004: 10.65% of its exports; import side 3.58%
- Rank within Sub-Chapter 3004: #2 of 149 by export value; import-side #4

### Key metrics

- Export CAGR: 30.78% (FY 2018-19 to FY 2024-25, 7 fiscal years)
- National export rank: #21 of 12657 HSN codes by export value (FY 2024-25)
- Peak growth year: +77.69% in FY 2022-23
- Contribution to Sub-Ch. 3004: 10.65% of its exports (FY 2024-25)

## India export-import trade statistics: HSN Code 30049049

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

| FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Sub-Ch. 3004 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Sub-Ch. 3004 | Trade balance | Exp rank |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY 2018-19 | 3,971.50 | 0.1738% | — | 4.27% | 329.06 | 0.0092% | — | 4.45% | +3,642.44 | #72 |
| FY 2019-20 | 3,629.92 | 0.1649% | −8.60% | 3.50% | 231.58 | 0.0069% | −29.62% | 3.04% | +3,398.34 | #79 |
| FY 2020-21 | 4,229.61 | 0.1966% | +16.52% | 3.27% | 279.96 | 0.0096% | +20.89% | 3.50% | +3,949.65 | #69 |
| FY 2021-22 | 5,013.97 | 0.1598% | +18.54% | 3.94% | 244.01 | 0.0053% | −12.84% | 1.85% | +4,769.96 | #83 |
| FY 2022-23 | 8,909.14 | 0.2461% | +77.69% | 6.30% | 308.14 | 0.0054% | +26.28% | 3.25% | +8,601.00 | #41 |
| FY 2023-24 | 12,792.42 | 0.3536% | +43.59% | 7.87% | 259.69 | 0.0046% | −15.72% | 2.66% | +12,532.73 | #31 |
| FY 2024-25 | 19,872.43 | 0.5399% | +55.35% | 10.65% | 384.20 | 0.0063% | +47.95% | 3.58% | +19,488.23 | #21 |

- CAGR (7-year): exports 30.78%/yr, imports 2.62%/yr (consistently Surplus)

## Key trade insights: HSN Code 30049049 export-import analysis

### Consistent export growth: 30.78% CAGR over 7 years

India's exports under HSN Code 30049049 have grown at a compound annual rate of 30.78% over 7 fiscal years, rising from ₹3,971.50 Crore in FY 2018-19 to ₹19,872.43 Crore in FY 2024-25.

### HSN Code 30049049 ranked #21 among all 12657 HSN codes by export value

In FY 2024-25, HSN Code 30049049 ranks #21 out of 12657 HSN codes by total export value. Within Sub-Chapter 3004, it ranks #2 of 149. By trade surplus, it ranks #18 of 12657.

### FY 2022-23 was the strongest growth year for HSN Code 30049049 exports

The strongest single-year export movement for HSN Code 30049049 was recorded in FY 2022-23, when exports surged by 77.69% over the prior year.

### India maintains a trade surplus of ₹19,488.23 Crore in HSN Code 30049049 goods

In FY 2024-25, India's exports of ₹19,872.43 Cr exceeded imports of ₹384.20 Cr, resulting in a trade surplus of ₹19,488.23 Crore — ranking #18 of 12657 by surplus magnitude.

### Import growth of 2.62% CAGR signals stable import dependency for Other | Anticancer Drugs

India's imports under HSN Code 30049049 have grown at 2.62% CAGR, reaching ₹384.20 Crore in FY 2024-25.

### HSN Code 30049049 contributes 10.65% of Sub-Chapter 3004 exports — ranked #2

Among the 149 HSN codes under Sub-Chapter 3004, HSN Code 30049049 ranks #2 by export value — accounting for 10.65% of the sub-chapter's total exports in FY 2024-25. On the import side, it holds 3.58% share (rank #4).

## Related HSN Codes in Sub-Chapter 3004

Ranked by export value (FY 2024-25).

| Rank | HSN Code | Exports (FY 2024-25) |
| --- | --- | --- |
| #1 | [HSN Code 30049099: Other therapeutic or prophylactic use products](https://busy.in/hsn/hsn-30049099/) | ₹82,761 Cr |
| #2 | HSN Code 30049049: Other \| Anticancer Drugs (this hsn code) | ₹19,872 Cr |
| #3 | [HSN Code 30049079: Other \| Antihypertensive Drugs](https://busy.in/hsn/hsn-30049079/) | ₹9,153 Cr |
| #4 | [HSN Code 30049069: Nonsteroidal Analgesics & Antipyretics: Other Medicaments](https://busy.in/hsn/hsn-30049069/) | ₹7,577 Cr |
| #5 | [HSN Code 30049039: Other Antihistaminics/Antacids/Antiulcer/Antiemetics](https://busy.in/hsn/hsn-30049039/) | ₹5,465 Cr |
| #6 | [HSN Code 30041090: Other Penicillins or Streptomycins](https://busy.in/hsn/hsn-30041090/) | ₹3,685 Cr |
| #7 | [HSN Code 30042019: Other Cephalosporin Antibiotics](https://busy.in/hsn/hsn-30042019/) | ₹3,036 Cr |
| #8 | [HSN Code 30049081: Antiepileptic & Sulfa Drugs](https://busy.in/hsn/hsn-30049081/) | ₹2,870 Cr |
| #9 | [HSN Code 30049082: Other Antiepileptic Drugs](https://busy.in/hsn/hsn-30049082/) | ₹2,860 Cr |
| #10 | [HSN Code 30049029: Other Anthelmintic/Antiamoebic/Antifungal Drugs](https://busy.in/hsn/hsn-30049029/) | ₹2,697 Cr |